XML 55 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment and Related Information (Tables)
12 Months Ended
Jun. 30, 2017
Segment Reporting [Abstract]  
Schedule of Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense

The Company evaluates segment performance based on income (loss) before interest income and other income and expense.

 

 

Diagnostics

 

 

Other

 

 

Total

 

Year ended June 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

722.1

 

 

$

49.3

 

 

$

771.4

 

Depreciation and amortization

 

 

42.8

 

 

 

5.5

 

 

 

48.3

 

Segment operating income (loss)

 

 

130.9

 

 

 

(81.5

)

 

 

49.4

 

Year ended June 30, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

705.7

 

 

$

48.1

 

 

$

753.8

 

Depreciation and amortization

 

 

21.5

 

 

 

5.2

 

 

 

26.7

 

Segment operating income (loss)

 

 

239.3

 

 

 

(72.5

)

 

 

166.8

 

Year ended June 30, 2015:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

695.5

 

 

$

27.6

 

 

$

723.1

 

Depreciation and amortization

 

 

20.5

 

 

 

4.5

 

 

 

25.0

 

Segment operating income (loss)

 

 

217.1

 

 

 

(82.9

)

 

 

134.2

 

 

 

 

Years Ended June 30,

 

 

 

2017

 

 

2016

 

 

2015

 

Total operating income for reportable segments

 

$

49.4

 

 

$

166.8

 

 

$

134.2

 

Unallocated amounts:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

1.2

 

 

 

0.9

 

 

 

0.4

 

Interest Expense

 

 

(6.0

)

 

 

(0.3

)

 

 

(0.2

)

Change in the fair value of contingent consideration

 

 

0.8

 

 

 

 

 

 

 

Other

 

 

(2.5

)

 

 

1.5

 

 

 

0.5

 

Income from operations before income taxes

 

 

42.9

 

 

 

168.9

 

 

 

134.9

 

Income tax provision

 

 

21.3

 

 

 

43.6

 

 

 

54.7

 

Net income

 

 

21.6

 

 

 

125.3

 

 

 

80.2

 

Net loss attributable to non-controlling interest

 

 

(0.2

)

 

 

 

 

 

 

Net income attributable to Myriad Genetics, Inc. stockholders

 

$

21.8

 

 

$

125.3

 

 

$

80.2

 

 

Schedule Of Comparison of Balance Sheet Assets by Operating Segment

The following table sets forth a comparison of balance sheet assets by operating segment:

 

 

 

June 30,

 

 

 

2017

 

 

2016

 

Net equipment, leasehold improvements and property:

 

 

 

 

 

 

 

 

Diagnostics

 

 

20.2

 

 

 

26.3

 

Other

 

 

30.9

 

 

 

32.0

 

Total

 

$

51.1

 

 

$

58.3

 

Total Assets:

 

 

 

 

 

 

 

 

Diagnostics

 

 

900.9

 

 

 

512.4

 

Other

 

 

124.3

 

 

 

129.2

 

Total

 

$

1,025.2

 

 

$

641.6

 

 

Summary of Assets by Geographical Region

The following table reconciles assets by geographical region:

 

 

 

June 30,

 

 

 

2017

 

 

2016

 

Net equipment, leasehold improvements and property:

 

 

 

 

 

 

 

 

United States

 

 

27.6

 

 

 

33.6

 

Rest of world

 

 

23.5

 

 

 

24.7

 

Total

 

$

51.1

 

 

$

58.3

 

Total Assets:

 

 

 

 

 

 

 

 

United States

 

 

912.8

 

 

 

532.6

 

Rest of world

 

 

112.4

 

 

 

109.0

 

Total

 

$

1,025.2

 

 

$

641.6

 

 

Reconciliation of Assets by Operating Segment and Geographic Region to Total Assets

The following table reconciles assets by operating segment and geographic region to total assets:

 

 

 

June 30,

 

 

 

2017

 

 

2016

 

Total assets by segment and geographical region

 

$

1,025.2

 

 

$

641.6

 

Cash, cash equivalents, and marketable investment

   securities (1)

 

 

199.2

 

 

 

238.9

 

Total

 

$

1,224.4

 

 

$

880.5

 

 

(1)

The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments